A detailed history of Acadian Asset Management LLC transactions in Spruce Biosciences, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 1,259,151 shares of SPRB stock, worth $629,575. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,259,151
Previous 1,367,997 7.96%
Holding current value
$629,575
Previous $707,000 15.56%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$0.42 - $0.59 $45,715 - $64,219
-108,846 Reduced 7.96%
1,259,151 $597,000
Q2 2024

Aug 06, 2024

BUY
$0.51 - $0.85 $509,574 - $849,291
999,166 Added 270.9%
1,367,997 $707,000
Q1 2024

May 10, 2024

BUY
$0.7 - $5.49 $258,181 - $2.02 Million
368,831 New
368,831 $289,000
Q1 2022

May 12, 2022

SELL
$1.85 - $4.59 $132,748 - $329,360
-71,756 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$2.33 - $5.74 $167,191 - $411,879
71,756 New
71,756 $318,000

Others Institutions Holding SPRB

About SPRUCE BIOSCIENCES, INC.


  • Ticker SPRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,560,200
  • Market Cap $11.8M
  • Description
  • Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...
More about SPRB
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.